CRS: BJMC
Position: Community Coordinator
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
Primary Objective To obtain sputum, serum, urine, and peripheral blood mononuclear cells (PBMCs) for central TB biorepository...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
